{"id":"ckd-828-placebo","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo formulation, CKD-828(placebo) contains no active pharmaceutical ingredient and serves as a control comparator in phase 3 clinical trials. It is used to establish the efficacy and safety profile of the active drug candidate through blinded comparison. Placebo responses help distinguish true drug effects from natural disease progression and observer bias.","oneSentence":"CKD-828 is a placebo control used in clinical trials and has no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:06:13.123Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04388215","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2019-10-23","conditions":"Hypertension, Dyslipidemias","enrollment":120},{"nctId":"NCT01983735","phase":"PHASE3","title":"Efficacy and Safety of TELMINUVO to Stage 2 Hypertension","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2014-01","conditions":"Hypertension","enrollment":200},{"nctId":"NCT01634295","phase":"PHASE3","title":"Efficacy and Safety of CKD-828 to Stage 2 Hypertension","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2012-07","conditions":"Hypertension","enrollment":103},{"nctId":"NCT01128322","phase":"PHASE2","title":"CKD-828 Primary Hypertension Trial(Dose-selection)","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2010-07","conditions":"Hypertension","enrollment":430}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CKD-828(placebo)","genericName":"CKD-828(placebo)","companyName":"Chong Kun Dang Pharmaceutical","companyId":"chong-kun-dang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}